|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.0002 - 0.0003|
|52 Week Range||0.0000 - 0.0006|
|Beta (3Y Monthly)||0.38|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
DALLAS, Dec. 12, 2018 -- via OTC PR WIRE -- North American Cannabis Holdings, Inc. (USOTC: USMJ) (“USMJ”) CEO and Chairman, Steven Rash, today reacted to recent news following.
DALLAS, Dec. 10, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- North American Cannabis Holdings, Inc. (USOTC: USMJ) (“USMJ”) today released a letter from its CEO and Chairman discussing the potential for the overall cannabis industry to be realized from the 2018 Farm Act that includes, as drafted, the legalization of hemp farming. The letter is intended for all with an interest in the U.S. cannabis industry and specifically for those invested in any of the USMJ family of companies. Steven Rash, CEO and Chairman of USMJ is also one of its founders.
DALLAS, Nov. 27, 2018 -- via OTC PR WIRE -- Puration, Inc. (USOTC: PURA) and Kali, Inc. (USOTC: KALY) today announced a letter to shareholders from the incoming CEO of Kali,.
DALLAS, Texas, Nov. 23, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Puration, Inc. (USOTC: PURA) (“PURA”) with Kail, Inc. (USOTC: KALY) (“KALY”) and Nouveau Life Pharmaceuticals, Inc. (USOTC: NOUV) (“NOUV”) today announced appointed Steven Rash as CEO of the US Cannabis Health LLC. The three companies have each contributed assets in exchange for respective 30% stakes in US Cannabis Health which has been set up to develop cannabis pharmaceutical and wellness therapies estimated to be a $50 Billion market by 2029. An online presentation was recently released detailing the contributions of each of the three corporations to US Cannabis Health in addition to providing an overview of the JV’s business plan. Steven Rash is both a healthcare industry veteran and cannabis industry veteran. Mr. Rash is a founder and current CEO of North American Cannabis Holdings, (USOTC: USMJ) (“USMJ”). Mr. Rash is a medical industry veteran with a lengthy list of career accomplishments and experiences. He has negotiated medical device licensing agreements and health care partner strategic alliances that combined have generated over $650 million in new revenues.
DALLAS, Nov. 05, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Puration, Inc. (USOTC: PURA) (“PURA”) today released an online presentation with details on the recent acquisition of the Telluride Health Company and the plans for integrating the operation into PURA’s overall cannabis beverage business model. The presentation includes an explanation of how PURA fits into the ACI Conglomerated portfolio in conjunction with ACI’s other holdings, North American Cannabis Holdings (USMJ), Priority Aviation (PJET) and Nouveau Life Pharmaceuticals (NOUV). The presentation is available on the company’s website. The narrative from the presentation is included in its entirety below.
SARASOTA, Fla., Nov. 02, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali, Inc. (USOTC: KALY) today published the online presentation included here below to detail the strategy behind the recently announced plans with Puration, Inc. (USOTC: PURA) and Nouveau Life Pharmaceuticals, Inc. (USOTC: NOUV) to form a joint venture (JV) company to develop cannabis pharmaceutical products. The cannabis pharmaceutical market is anticipated to reach a value of $50 billion by 2029. KALY has partnered with PURA and NOUV to form US Cannabis Health, a JV company formed for the development of cannabis pharmaceutical and wellness products. The cannabis pharmaceuticals market is forecasted to reach a $50 billion sales by 2029.
DALLAS, Oct. 31, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Puration, Inc. (PURA) today confirmed the developing joint venture agreement with Kali, Inc. (KALY) and Nouveau Life Pharmaceuticals, Inc. (NOUV) to develop cannabis pharmaceutical products. Puration further confirms plans to host representatives from Kali and Nouvea in Dallas next week to finalize JV details. “Puration is already in the wellness market and think our experience with the NCM Biotech Cannabis extraction patent will be valuable to the JV,” said Brian Shibley CEO of Puration.
SARASOTA, Fla., Oct. 31, 2018 -- via OTC PR WIRE -- Kali, Inc. (USOTC: KALY) today announced an online presentation scheduled Friday, November 2nd, 2018 to detail the strategy.
SARASOTA, Fla., Oct. 29, 2018 -- via OTC PR WIRE -- Kali, Inc. (USOTC: KALY) today announced entering into discussions with Puration, Inc. (USOTC: PURA) and Nouveau Life.
PURA announced last week the spinoff of its cannabis cultivation business. The spinoff is part of the overall strategy for Puration to concentrate ongoing business development efforts on the company’s flourishing cannabis infused beverage business. The spinoff announced last week has been effected through the execution of a securities exchange agreement with Nouveau Life Pharmaceuticals, Inc., (USOTC: NOUV) (“NOUV”). PURA has sold its cannabis cultivation business in exchange for a convertible purchase note issued by NOUV. All of the NOUV common shares issued in conversion of the purchase note are slated for distribution to PURA shareholders in a dividend distribution following a recapitalization of NOUV. More details on the company’s rapidly expanding cannabis beverage business to include further details on the spinoff transaction will be included in an online presentation this Thursday, October 11th, 2018.
DALLAS, Oct. 05, 2018 -- via OTC PR WIRE -- Puration, Inc. (USOTC: PURA) (“PURA”) today announced a letter of intent to acquire a new cannabis beverage company. The Company.